Learn more about the evolution of pharma decision-making at www.captario.com
3 articles about Captario
Captario is pleased to announce that Sobi®, one of the largest Swedish biopharmaceutical companies developing and providing sustainable access to innovative medicines for the treatment of rare diseases, has stepped ahead of their peers’ digital journey by choosing to partner with Captario in their efforts to increase efficiency in their strategic drug development initiatives.
Captario, the life science SaaS-platform decision analytics company, announces the launch of Professional Services to further enable strategic decision-making throughout the drug development process.
Captario Has Been Selected by Alnylam Pharmaceuticals To Optimize Their Portfolio Management Process
Captario, a Gothenburg-based life sciences decision analytics SaaS platform & services company, has been chosen by Alnylam Pharmaceuticals, a global biopharmaceutical company based in Cambridge, MA, to support their digital transformation journey of optimizing strategic project and portfolio forecasting and modeling. Focused on the discovery,